International Scholarly Research Notices / 2012 / Article / Tab 1

Research Article

Construction of a Drug Safety Assurance Information System Based on Clinical Genotyping

Table 1

Points in first part of dose curve.

SequenceXY

1.05 PT.005 PPC
2.1 PT.12 PPC
3.15 PT.23 PPC
4.2 PT.36 PPC
5.25 PT.50 PPC
6.3 PT.66 PPC
7.35 PT.75 PPC
8.4 PT.82 PPC
9.45 PT.87 PPC
10.5 PT.90 PPC
11.55 PT.92 PPC
12.6 PT.94 PPC
13.65 PT.96 PPC
14.70 PT.97 PPC
15.75 PT.98 PPC
16.80 PT.99 PPC
17.85 PT.993 PPC
18.90 PT.996 PPC
19.95 PT.998 PPC
201.0 PT1.0 PPC
211.05 PT.998 PPC

PT = % of peak time
PPC = % of peak plasma concentration.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.